Oxford Biomedica inks agreement to boost UK supply of AstraZeneca’s COVID-19 vaccine

Gene and cell therapy firm Oxford Biomedica said on Monday it signed a new manufacturing agreement to help it scale up production of AstraZeneca’s potential COVID-19 vaccine to cater to demand in the United Kingdom and Europe.

Want to know more on

Oxford Biomedica inks agreement to boost UK supply of AstraZeneca’s COVID-19 vaccine

click here go to market news source. Market news summary from Reuters Market News.Author: …

From -

click here go to market news source.
Market news summary from Reuters Market News.
Author:



Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Categories

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close